A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Shonan ShoColin M CourtPaul WinogradMarcia M RussellJames S TomlinsonPublished in: Journal of surgical oncology (2017)
Our proposed mutation panel identifies CRC patients at high-risk for recurrence, which may help guide adjuvant therapy and post-operative surveillance protocols.